Carvedilol As A Potential Addition To The Covid-19 Therapeutic Arsenal
Int J Pharm Pharm Sci
;
2020 Jun; 12(6): 81-86
Artículo
| IMSEAR
| ID: sea-206114
ABSTRACT
No single therapeutic agent has been recognized so far as the ultimate treatment for COVID-19 and many treatment strategies rely on associating different medications with proven or hypothetical anti-viral effects. Carvedilol is a third-generation beta-blocker displaying potential inhibitory properties on several key enzymatic processes and pathways involved in SARS-CoV-2 or other coronaviruses replication, in addition to the modulatory effect on several inflammatory messengers of COVID-19. These data could provide a reasonable hypothetical background for further investigating specific anti-SARS-CoV-2 effects and could pave the way for further clinical verification.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Revista:
Int J Pharm Pharm Sci
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS